Discovering The Potential of AOX1: A Key Enzyme in Cellular Metabolism

Target Name: AOX1

NCBI ID: G316

AOX1

Discovering The Potential of AOX1: A Key Enzyme in Cellular Metabolism

AOX1 (Aldehyde oxidase) is a protein that is expressed in a variety of tissues throughout the body, including the liver, pancreas, and lungs. It is a key enzyme that is involved in the metabolism of aldehydes, which are molecules that contain a carbonyl group. This article will discuss the biology and function of AOX1, as well as its potential as a drug target or biomarker.

The Biology of AOX1

AOX1 is a 22-kDa protein that is expressed in the cytoplasm of cultured cells. It is a member of the superfamily of cytoplasmic enzymes known as the NAD+-dependent aldehyde oxidase subfamily 1. These enzymes are involved in the oxidation of various molecules, including aldehydes, to produce carbonyl groups.

In humans, AOX1 is expressed in a variety of tissues, including the liver, pancreas, and lungs. It is highly expressed in the liver, which is the primary site of its synthesis and storage. In the pancreas, AOX1 is expressed in the islet cells, which produce insulin. In the lungs, AOX1 is expressed in the alveolar macrophages, which are responsible for phagocytosis and eliminate airborne particles.

The Function of AOX1

AOX1 is involved in the metabolism of a wide variety of aldehydes, including those that are produced by cellular metabolism or that are derived from environmental sources such as drugs or other substances. It is a key enzyme in the detoxification of many of these aldehydes, producing carbonyl groups that can be involved in a variety of cellular processes.

One of the key functions of AOX1 is its role in the detoxification of xenobiotics, which are drugs or other substances that are harmful to the body. Many of these xenobiotics are metabolized to produce carbonyl groups, which can interact with AOX1 and cause damage to the cellular structure and function. By producing these carbonyl groups, AOX1 helps to protect the cell from the harmful effects of these xenobiotics.

In addition to its role in detoxification, AOX1 is also involved in the metabolism of other molecules that are important for cellular function. For example, it is involved in the production of reactive oxygen species (ROS), which can damage cellular structures and contribute to a variety of cellular processes including cell death and inflammation.

The Potential as a Drug Target or Biomarker

The ability of AOX1 to produce carbonyl groups has made it an attractive target for drug development. Many drugs that are used to treat a variety of diseases, including cancer, have been shown to produce carbonyl groups, which can interact with AOX1 and cause damage to the cellular structure and function.

One of the key advantages of targeting AOX1 with drugs is that it is a widely expressed protein that is present in many different tissues throughout the body, making it an attractive target for both diagnostic and therapeutic applications. In addition, because AOX1 is involved in a variety of cellular processes that are important for human health, targeting it with drugs is expected to have a more general and beneficial effect on cellular function.

Another potential advantage of targeting AOX1 is that it is a protein that is expressed in the cytoplasm of cultured cells, which makes it an attractive target for drugs that act on the cytoplasm. This is because many drugs that act on the cytoplasm are able to penetrate the cell membrane and interact with AOX1 within the cytoplasm.

In addition to its potential as a drug target, AOX1 is also a potential biomarker for a variety of diseases. Its production of carbonyl groups has been associated with a variety of cellular processes that are important for human health, including the development and progression of cancer. Therefore,

Protein Name: Aldehyde Oxidase 1

Functions: Oxidase with broad substrate specificity, oxidizing aromatic azaheterocycles, such as N1-methylnicotinamide, N-methylphthalazinium and phthalazine, as well as aldehydes, such as benzaldehyde, retinal, pyridoxal, and vanillin. Plays a key role in the metabolism of xenobiotics and drugs containing aromatic azaheterocyclic substituents. Participates in the bioactivation of prodrugs such as famciclovir, catalyzing the oxidation step from 6-deoxypenciclovir to penciclovir, which is a potent antiviral agent. Is probably involved in the regulation of reactive oxygen species homeostasis. May be a prominent source of superoxide generation via the one-electron reduction of molecular oxygen. May also catalyze nitric oxide (NO) production via the reduction of nitrite to NO with NADH or aldehyde as electron donor. May play a role in adipogenesis

The "AOX1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AOX1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets